BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30891247)

  • 1. Jazia prime vendor system- a public-private partnership to improve medicine availability in Tanzania: from pilot to scale.
    Wiedenmayer K; Mbwasi R; Mfuko W; Mpuya E; Charles J; Chilunda F; Mbepera D; Kapologwe N
    J Pharm Policy Pract; 2019; 12():4. PubMed ID: 30891247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing public-private procurement practices for medical commodities in Dar Es Salaam: a situation analysis.
    Mbwasi R; Mbepera D; Mfuko W; Makanzo J; Kikwale M; Canavan R; Stoermer M; Wiedenmayer K
    BMC Health Serv Res; 2022 Dec; 22(1):1523. PubMed ID: 36517787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability of a Prime Vendor System in Public Healthcare Facilities in Tanzania.
    Kuwawenaruwa A; Tediosi F; Metta E; Obrist B; Wiedenmayer K; Msamba VS; Wyss K
    Int J Health Policy Manag; 2021 Oct; 10(10):625-637. PubMed ID: 32610764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost and cost drivers associated with setting-up a prime vendor system to complement the national medicines supply chain in Tanzania.
    Kuwawenaruwa A; Wyss K; Wiedenmayer K; Tediosi F
    BMJ Glob Health; 2020 Sep; 5(9):. PubMed ID: 32928801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of accountability in the performance of Jazia prime vendor system in Tanzania.
    Kuwawenaruwa A; Tediosi F; Obrist B; Metta E; Chiluda F; Wiedenmayer K; Wyss K
    J Pharm Policy Pract; 2020; 13():25. PubMed ID: 32523700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of prime vendor system on availability of medicines and medical supplies in the selected public health facilities in Arusha district council.
    Elias L; Mushi L
    BMC Health Serv Res; 2024 Feb; 24(1):161. PubMed ID: 38303051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Jazia Prime Vendor System in ensuring availability of health commodities in Singida Region, Tanzania: a pre- and post-evaluation study.
    Pyuza D; Mitiku S; Swalehe O; Kagisha V; Njunwa KJ
    J Pharm Policy Pract; 2023 Nov; 16(1):150. PubMed ID: 37986126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking the Community Health Fund with Accredited Drug Dispensing Outlets in Tanzania: exploring potentials, pitfalls, and modalities.
    Dillip A; Kalolo A; Mayumana I; Rutishauser M; Simon VT; Obrist B
    J Pharm Policy Pract; 2022 Dec; 15(1):106. PubMed ID: 36582002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMS for Life: a pilot project to improve anti-malarial drug supply management in rural Tanzania using standard technology.
    Barrington J; Wereko-Brobby O; Ward P; Mwafongo W; Kungulwe S
    Malar J; 2010 Oct; 9():298. PubMed ID: 20979633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial procurement in private-sector pharmaceutical outlets: decision-making complexities and implications for medicine quality in Tanzania.
    Mshana G; Mayebe T; Balira R; Hamill H; Hampshire K
    BMJ Glob Health; 2023 Sep; 6(Suppl 3):. PubMed ID: 37696543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of medicines availability and stock-outs on household's utilization of healthcare services in Dodoma region, Tanzania.
    Kuwawenaruwa A; Wyss K; Wiedenmayer K; Metta E; Tediosi F
    Health Policy Plan; 2020 Apr; 35(3):323-333. PubMed ID: 31942625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Direct Health Facility Financing Program in Improving Maternal Health Services in Pangani District, Tanzania.
    Tukay SM; Pasape L; Tani K; Manzi F
    Int J Womens Health; 2021; 13():1227-1242. PubMed ID: 34916854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
    ; Tougher S; Hanson K; Goodman C
    Malar J; 2017 Apr; 16(1):173. PubMed ID: 28441956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-sectional pilot study assessing needs and attitudes to implementation of Information and Communication Technology for rational use of medicines among healthcare staff in rural Tanzania.
    Nilseng J; Gustafsson LL; Nungu A; Bastholm-Rahmner P; Mazali D; Pehrson B; Eriksen J
    BMC Med Inform Decis Mak; 2014 Aug; 14():78. PubMed ID: 25158806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reality of task shifting in medicines management- a case study from Tanzania.
    Wiedenmayer KA; Kapologwe N; Charles J; Chilunda F; Mapunjo S
    J Pharm Policy Pract; 2015; 8(1):13. PubMed ID: 25893096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational use of medicines - Indian perspective!
    Mohanta GP; Manna PK
    Int J Risk Saf Med; 2015; 27 Suppl 1():S47-8. PubMed ID: 26639706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Role of Accredited Drug Dispensing Outlets in Tanzania's Health System.
    Embrey M; Vialle-Valentin C; Dillip A; Kihiyo B; Mbwasi R; Semali IA; Chalker JC; Liana J; Lieber R; Johnson K; Rutta E; Kimatta S; Shekalaghe E; Valimba R; Ross-Degnan D
    PLoS One; 2016; 11(11):e0164332. PubMed ID: 27824876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania.
    Ewen M; Kaplan W; Gedif T; Justin-Temu M; Vialle-Valentin C; Mirza Z; Regeer B; Zweekhorst M; Laing R
    J Pharm Policy Pract; 2017; 10():7. PubMed ID: 28116107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prices, availability and affordability of medicines in Rwanda.
    Bizimana T; Kayumba PC; Heide L
    PLoS One; 2020; 15(8):e0236411. PubMed ID: 32745100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.
    Fang Y; Wagner AK; Yang S; Jiang M; Zhang F; Ross-Degnan D
    Lancet Glob Health; 2013 Oct; 1(4):e227-37. PubMed ID: 25104348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.